Bioequivalence Study of Raperazole 20mg DR Tabs and PARIET® 20 mg DR Tabs Under Fed Conditions
Clinical trial NCT02605395 · COMPLETED
Trial details
- NCT number
- NCT02605395
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-22
- Primary completion
- 2014-03-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.